Phase 1/2 Study of Anti GM-2 Monoclonal Antibody To Treat Multiple Myeloma

Clinical trial NCT00775502 · TERMINATED

Trial details

NCT number: NCT00775502
Sponsor: Kyowa Kirin Co., Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2008-10-01
Primary completion: 2011-05-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.